Why scientists are racing to develop more COVID antivirals

Max Kozlov

Nature, 2022, vol. 601, issue 7894, 496-496

Abstract: The first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.

Keywords: Medical research; SARS-CoV-2; Drug discovery (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-022-00112-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:601:y:2022:i:7894:d:10.1038_d41586-022-00112-8

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-022-00112-8

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().